XML 59 R40.htm IDEA: XBRL DOCUMENT v3.20.4

Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Segment Data Schedule

Segment data were as follows:

			For the Years Ended December 31,
(in millions)			2020						2019						2018
Net revenues:
Smokeable products			$	23,089					$	21,996					$	22,297
Oral tobacco products			2,533						2,367						2,262
Wine			614						689						691
All other			(83)						58						114
Net revenues			$	26,153					$	25,110					$	25,364
Earnings before income taxes:
Operating companies income (loss):
Smokeable products			$	9,985					$	9,009					$	8,408
Oral tobacco products			1,718						1,580						1,431
Wine			(360)						(3)						50
All other			(172)						(16)						(421)
Amortization of intangibles			(72)						(44)						(38)
General corporate expenses			(227)						(199)						(315)
Corporate asset impairment and exit costs			1						(1)						—
Operating income			10,873						10,326						9,115
Interest and other debt expense, net			(1,209)						(1,280)						(665)
Net periodic benefit income, excluding service cost			77						37						34
Income (losses) from equity investments			(111)						1,725						890
Impairment of JUUL equity securities			(2,600)						(8,600)						—
Loss on Cronos-related financial instruments			(140)						(1,442)						—
Loss on ABI/SABMiller business combination			—						—						(33)
Earnings before income taxes			$	6,890					$	766					$	9,341

Schedule of Depreciation Expense and Capital Expenditures of Segments

Details of Altria’s depreciation expense and capital expenditures were as follows:

			For the Years Ended December 31,
(in millions)			2020						2019						2018
Depreciation expense:
Smokeable products			$	81					$	88					$	90
Oral tobacco products			32						27						28
Wine			40						41						40
General corporate and other			32						26						31
Total depreciation expense			$	185					$	182					$	189
Capital expenditures:
Smokeable products			$	49					$	61					$	81
Oral tobacco products			67						44						73
Wine			31						63						40
General corporate and other			84						78						44
Total capital expenditures			$	231					$	246					$	238

Schedule of Pre-tax Tobacco and Health Litigation Charges

For the years ended December 31, 2020, 2019 and 2018, pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s consolidated statements of earnings (losses) as follows:

(in millions)						2020						2019						2018
Smokeable products segment						$	79					$	72					$	103
Oral tobacco products segment						—						—						10
Interest and other debt expense, net						4						5						18
Total						$	83					$	77					$	131

X

- Definition

[Table Text Block] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]

+ References

No definition available.

+ Details

Name:	mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTableTextBlock
Namespace Prefix:	mo_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration